The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smirnova M.D.

Chazov National Medical Research Center for Cardiology

Svirida O.N.

Chazov National Medical Research Center for Cardiology

Blankova Z.N.

Chazov National Medical Research Center for Cardiology

Fofanova T.V.

Chazov National Medical Research Center for Cardiology

Vitsenya M.V.

Chazov National Medical Research Center for Cardiology

Ageev F.T.

Chazov National Medical Research Center for Cardiology

Depression as a predictor of high arterial stiffness in patients with low/moderate risk of cardiovascular complications

Authors:

Smirnova M.D., Svirida O.N., Blankova Z.N., Fofanova T.V., Vitsenya M.V., Ageev F.T.

More about the authors

Journal: Russian Cardiology Bulletin. 2023;18(4): 49‑55

Read: 1925 times


To cite this article:

Smirnova MD, Svirida ON, Blankova ZN, Fofanova TV, Vitsenya MV, Ageev FT. Depression as a predictor of high arterial stiffness in patients with low/moderate risk of cardiovascular complications. Russian Cardiology Bulletin. 2023;18(4):49‑55. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20231804149

Recommended articles:
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
Features of depressive diso­rders and suicidal beha­vior in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):7-13
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

References:

  1. Yusuf S, Hawken S, Ounpu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet. 2004;364(9438):937-952.  https://doi.org/10.1016/S0140-6736(04)17018-9
  2. Pogosova GV. Depression — a Risk Factor for Coronary Heart Disease and a Predictor of Coronary Death: 10 Years of Scientific Research. Kardiologiia. 2012;12:4-11. (In Russ.).
  3. Ladwig KH, Baumert J, Marten-Mittag B, Lukaschek K, Johar H, Fang X, Ronel J, Meisinger C, Peters A; KORA Investigators. for the KORA Investigators. Room for depressed and exhausted mood as a risk predictor for allcause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men. Atherosclerosis. 2017;257:224-231.  https://doi.org/10.1016/j.atherosclerosis.2016.12.003
  4. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression predicts cardiovascular disease in men: the Precursors Study. Archives of Internal Medicine. 1998;158 (13):1422-1426. https://doi.org/10.1001/archinte.158.13.1422
  5. Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, van Eijk JTM, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Archives of General Psychiatry. 2001;58:221-227.  https://doi.org/10.1001/archpsyc.58.3.221
  6. Smirnova MD, Svirida ON, Fofanova TV, Blankova ZN, Yarovaya EB, Ageev FT, Boytsov SA. Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up. Cardiovascular Therapy and Prevention. 2021;20(4):2762. (In Russ.). https://doi.org/10.15829/1728-8800-2021-2762
  7. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety and risk of subsequent coronary heart disease. 37-year follow-up of 49,321 young Swedish men. Journal of the American College of Cardiology. 2010;56(1):31-37.  https://doi.org/10.1016/j.jacc.2010.03.034
  8. Scherrer JF, Chrusciel T, Zeringue A, Garfield LD, Hauptman PJ, Lustman PJ, Freedland KE, Carney RM, Bucholz KK, Owen R, True WR. Anxiety Disorders Increase Risk for Incident Myocardial Infarction in Depressed and Nondepressed Veterans Administration Patients. American Heart Journal. 2010;159:772-779.  https://doi.org/10.1016/j.ahj.2010.02.033
  9. Meyer T, Buss U, Herrmann-Lingen C. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosomatic Medicine. 2010;72(1):9-15.  https://doi.org/10.1097/PSY.0b013e3181c64fc0
  10. Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E. Association of Depression and Anxiety With the 10-Year Risk of Cardiovascular Mortality in a Primary Care Population of Latvia Using the SCORE System. Frontiers in Psychiatry. 2018;9:276.  https://doi.org/10.3389/fpsyt.2018.00276
  11. Vorobyeva OV. Clinical features of depression in general medical practice (based on the results of the COMPASS program). Consilium Medicum. 2004;6(2):154-158. 
  12. Mermerelis A, Kyvelou SM, Vellinga A, Stefanadis C, Papageorgiou C, Douzenis A. Anxiety and Depression Prevalence in Essential Hypertensive. Patients is there an Association with Arterial Stiffness? Journal of Depression and Anxiety. 2018;7(2):304.  https://doi.org/10.4172/2167-1044.1000304
  13. Seldenrijk A, van Hout HPJ, van Marwijk HWJ, de Groot E, Gort J, Rustemeijer C, Diamant M, Penninx BWJH. Depression, Anxiety, and Arterial Stiffness. Biological Psychiatry. 2011;69(8):795-803.  https://doi.org/10.1016/j.biopsych.2010.12.034
  14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-370.  https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  15. Kim H-B, Wolf BJ, Kim J-H. Association of metabolic syndrome and its compo-nents with the risk of depressive symptoms: A systematic review and meta-analysis of cohort studies. Journal of Affective Disorders. 2023;323(15):46-54.  https://doi.org/10.1016/j.jad.2022.11.049
  16. Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biological Psychiatry. 2006;59:309-316.  https://doi.org/10.1016/j.biopsych.2005.07.010
  17. Medvedeva SO, Kolbasnikov SV. Severity of anxiety and depressive disorders and their relationship with cerebral and hemodynamic impairment in patients with arterial hypertension in the practice of general practitioner. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2016;116(12):109-111. (In Russ.) https://doi.org/10.17116/jnevro2016116121109-111
  18. Smirnova MI, Gorbunov VM, Andreeva GF, Molchanova OV, Fedorova EYu, Kalinina AM, Luk’ianov MM, Boytsov SA. Influence of seasonal and weather factors on cardiovascular and bronchopulmonary morbidity and mortality. Profilakticheskaya Meditsina. 2012;15(6):76-86. (In Russ.)
  19. Van Sloten T, Mitchell GF, Sigurdsson S, van Buchem MA, Jonsson PV, Garcia ME, Harris TB, Henry RMA, Levey AS, Stehouwer CDA, Gudnason V, Launer LJ. Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study. Journal of Psychiatry & Neuroscience. 2016;41(3):162-168.  https://doi.org/10.1503/jpn.140334
  20. Skibitsky VV, Skibitsky AV, Fendrikova AV. Influence of combination antihypertension therapy on the parameters of vessel wall rigidity in non-controlled arterial hypertension patients with depression. Russian Journal of Cardiology. 2016;4(132):76-82. (In Russ.). https://doi.org/10.15829/1560-4071-2016-4-76-82
  21. Wang CC, Lin SK, Tseng YF, Hsu CS, Tseng TC, Lin HH, Wang LY, Kao JH. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 2009;24(8):1411-1416. https://doi.org/10.1111/j.1440-1746.2009.05872.x
  22. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359(9311):995-1003.
  23. Consistent opinion of Russian experts on arterial stiffness assessment in clinical practice (RCO Congress, 2015). Kardiovaskulyarnaya terapiya i profilaktika. 2016;15(2):4-19. (In Russ.). https://doi.org/10.15829/1728-8800-2016-2-4-19

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.